Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 491 of 6351
-
New combo therapy aims to boost recovery after stroke
Disease control Not yet recruitingThis is a multicenter, randomized, open-label trial designed to evaluate the safety, feasibility, and efficacy of combining minimally invasive surgery (MIS) with intravenous deferoxamine (DFX) for the treatment of spontaneous intracerebral hemorrhage (ICH), compared to standard m…
Phase 2/3 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a new drug combo wipe out three parasitic diseases at once?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if mass drug administration with moxidectin in combination with diethylcarbamazine, and albendazole (MoxDA) can treat lymphatic filariasis, scabies and strongyloidiasis in children and adults living in communities where these diseases a…
Phase 3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 26, 2026 14:32 UTC
-
New TB tests for kids could save thousands of lives
Diagnosis Not yet recruitingStart4Kids: Evaluating the performance, feasibility, acceptability and cost effectiveness of computer-aided detection (CAD) of chest X-ray (CXR) and concurrent testing using novel diagnostics and non-sputum specimens for childhood tuberculosis (TB) in Bangladesh, Cameroon, Kenya …
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New stroke drug combo aims to boost recovery in Late-Treated patients
Disease control Not yet recruitingThis is a multicenter, randomized, open-label, blinded-endpoint clinical trial designed to evaluate the efficacy and safety of early administration of eptifibatide following intravenous thrombolysis in patients with acute ischemic stroke who present 4.5 to 24 hours after symptom …
Phase 3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for kids with Hard-to-Treat ITP: daratumumab takes on rituximab
Disease control Recruiting nowThis randomized, open-label study aim to compare the efficacy and safety of Daratumumab (anti-CD38 monoclonal antibody) with Rituximab in pediatric ITP patients.This study will be conducted in pediatric ITP patients who had not responded to or had relapsed after previous glucocor…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New cocktail of drugs aims to stop High-Risk throat cancer in its tracks
Disease control Not yet recruitingThis trial aimed to evaluate the efficacy of anlotinib hydrochloride combined with benmelstobart, induction chemotherapy, and concurrent chemoradiotherapy (IC+CCRT), versus a regimen of benmelstobart plus IC+CCRT, in patients with high-risk locoregionally advanced nasopharyngeal …
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New radiation therapy shows promise for Hard-to-Treat gut cancers
Disease control Recruiting nowGastro-enteropancreatic Neuro-endocrine tumors (GEP-NETs) are rare slow-growing cancers which commonly involve the abdominal organs like liver, stomach, intestines and pancreas. Their incidence has been documented to have increased over the last decade, thus resulting in treatmen…
Phase 2 • Sponsor: Tata Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Spinal stimulation + rehab aims to restore walking in spinal cord injury
Disease control Not yet recruitingInterventional prospective longitudinal on the evaluation of spinal cord stimulation (SCS) assisted by motor rehabilitation training for restoring motor function in patients with non-traumatic spinal cord injury (SCI). The investigators will enroll ten research participants with …
Sponsor: Albano Luigi • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New stitch procedure could help obese patients shed pounds without surgery
Disease control Not yet recruitingEGO-Trial is the first multicenter study in France which aims to evaluate the efficacy of Endoscopic Sleeve Gastroplasty (ESG) in patients with obesity. This project fills a critical national gap by providing real-world, multicentric data from diverse French healthcare settings, …
Sponsor: IHU Strasbourg • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New cholesterol drug QLC7401 enters final testing phase
Disease control Not yet recruitingTo evaluate the efficacy, safety and immunogenicity of QCL7401 subcutaneous administration in patients with primary hypercholesterolemia or mixed hyperlipidemia with poorly controlled LDL-C elevated on optimized lipid-lowering therapy.
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Triple therapy aims to turn inoperable bowel cancer into surgical candidates
Disease control Not yet recruitingTo evaluate the efficacy and safety of immune checkpoint inhibitor-based combination therapy with targeted therapy and chemotherapy in patients with locally advanced unresectable or metastatic colorectal cancer.
Phase 4 • Sponsor: Ye Xu • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Massive heart surgery trial aims to slash infection rates
Prevention Not yet recruitingThe goal of this pragmatic, multi-centre factorial cluster randomized cross-over trial is to assess the efficacy of a combination of cefazolin plus vancomycin compared to cefazolin monotherapy, as well as a comparison of short versus long-term prophylaxis with four study arms: 1)…
Phase 4 • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
New eye drug aims to match leading treatment for blinding disease
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy and safety of QL1207H injection versus aflibercept 8 mg in patients with neovascular age-related macular degeneration. The main question it aims to answer is: • Whether the efficacy and safety of QL1207H and aflibercept…
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI-Powered smartwatch ECG could spot hidden heart failure at home
Diagnosis Recruiting nowThis prospective multicenter observational study will validate the accuracy of a previously developed artificial intelligence-enabled single-lead electrocardiogram (AI-ECG) model for identifying low ejection fraction and other structural heart disease phenotypes. Adult participan…
Sponsor: National Defense Medical Center, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New hope for AML patients who fail standard therapy: experimental combo trial launches
Disease control Not yet recruitingThis is a multi-center, prospective, single-arm, phase 2 clinical study conducted in China to evaluate the efficacy and safety of Lisafotoclax combined with Decitabine and Homoharringtonine in patients with acute myeloid leukemia (AML) who have failed or are intolerant to prior t…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New urine test could spot bladder cancer without needles or scopes
Diagnosis Recruiting nowThis study will, for the first time, establish a non-invasive diagnostic model for bladder cancer based on CREPT expression levels in exfoliated urothelial cells using a multicenter cohort, and validate its value in the non-invasive diagnosis and recurrence monitoring of bladder …
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Could a simple vitamin boost plaque stability and cut stroke risk?
Disease control Recruiting nowThis is a prospective, exploratory, cohort clinical study aiming to further investigate the direct impact of folic acid on the stability of carotid atherosclerotic plaques, building upon substantial clinical evidence confirming that folic acid supplementation reduces the risk of …
Phase 1/2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a climate-smart pregnancy care program prevent stillbirths in a fast-growing city?
Prevention By invitation onlyTanzania's population is growing quickly, and Dar es Salaam is one of the fastest-growing cities in the world. At the same time, the city is increasingly affected by very hot weather, flooding, and air pollution. Many parts of Dar es Salaam do not have enough roads, drainage, hou…
Sponsor: University of Copenhagen • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Jump higher, sprint faster? a new training combo puts basketball power to the test
Disease control CompletedThis randomized controlled trial evaluated the effects of 12 weeks of French Contrast Training (FCT) compared with traditional resistance training (RT) on lower-limb explosive performance in male collegiate basketball players. Forty participants were randomly assigned in a 1:1 ra…
Sponsor: Ziren Zhao • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a single drug dose make repeat hypospadias surgery safer?
Disease control OngoingThis study aims to fill that gap by evaluating the efficacy and safety of intravenous TXA in children undergoing redo hypospadias surgery, potentially establishing a new standard of care
Sponsor: Aswan University Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC